sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> cancer immunotherapy market

report

Cancer Immunotherapy Market, by Product Types (Vaccines, Monoclonal Antibodies, Immunomodulators, Cell Therapies), Applications (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Multiple Myeloma, Head and Neck Cancer), End-users (hospitals, Clinics) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC209 December 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the cancer immunotherapy market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cancer immunotherapy market.The scope of this report covers the cancer immunotherapy market by its major segments, which include the product types, applications, end-users and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Extensive analysis of the key players dominating the competitive landscape of this market
  • Meticulous understanding of the key new market opportunities in individual geographic regions/countries
  • Detailed analysis of the significant sustainability strategies adopted by the major players in this market
  • Detailed analysis of the geographic region that will witness the strongest growth

KEY PREMIUM INSIGHTS:

  • Increasing incidences of cancer over the past few decades are expected to boost the cancer immunotherapy market.
  • The advantages and effectiveness of immunotherapy over the conventional treatments are expected to increase the demand for the immunotherapy market.
  • Increasing awareness of immunotherapy in developed countries is analyzed to increase the demand for cancer immunotherapy market during the forecast period.
  • However, the stringent regulatory norms is likely to hinder the market growth.
  • Moreover, the lack of awareness about cancer immunotherapy over the conventional treatments in the developing regions may hamper the market growth during the forecast period.
  • Apart from that, saturated market scenario is also likely to create hindrance for the small market players in the cancer immunotherapy market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s cancer immunotherapy market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

KEY TARGET AUDIENCE

  • Drug Manufacturing Companies
  • Suppliers and Distributors of Cancer Immunotherapy
  • Hospitals and Diagnostic Centers
  • Ambulatory Surgery Centers
  • Academic Centers
  • Venture Capitalists

MARKET SEGMENTATION

This report analyzes the cancer immunotherapy market by the following segments:

  • Cancer Immunotherapy Market, by Product types
    • Vaccines
    • Monoclonal Antibodies
    •  Immunomodulators 
    • Cell Therapies
  • Cancer Immunotherapy Market, by Applications
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
    • Colorectal cancer
    • Multiple Myeloma
    • Head and Neck Cancer
    • Other Cancers
  • Cancer Immunotherapy Market, by End-users
    • Hospitals
    • Clinics
    • Others

KEY MARKET PLAYERS

  • AstraZeneca
  • Amgen
  • Bayer AG
  • F. Hoffman La-Roche Ltd.
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • Merck
  • Janssen Global Services, LLC
  • Pfizer
  • Novartis

GEOGRAPHIC COVERAGE AND ANALYSIS

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST& AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East& Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

Cancer Immunotherapy Market

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
      1. Vertical Analysis
  5. CANCER IMMUNOTHERAPY MARKET, BY PRODUCT TYPES
    1. Segment Share
    2. Product Types
      1.  Vaccines
      2. Monoclonal Antibodies
      3.  Immunomodulators 
      4. Cell Therapies
  6. CANCER IMMUNOTHERAPY MARKET, BY APPLICATIONS
    1. Segment Share
    2. Applications
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Colorectal cancer
      5. Multiple Myeloma
      6. Head and Neck Cancer
      7. Other Cancers
  7. CANCER IMMUNOTHERAPY MARKET, BY END-USERS
    1. Segment Share
    2. End-users
      1. Hospitals
      2. Clinics
      3. Others
  8. CANCER IMMUNOTHERAPY MARKET, BY GEOGRAPHY
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Product Types
      3. By Applications
      4. By End-users
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Product Types
      3. By Applications
      4. By End-users
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product Types
      3. By Applications
      4. By End-users
    4. Middle East& Africa
      1. By Country
        1. GCC
        2. North Africa
        3. South Africa
        4. Rest of Middle East& Africa
      2. By Product Types
      3. By Applications
      4. By End-users
    5. Latin America
      1. By Country
        1. Brazil
        2. Rest of Latin America
      2. By Product Types
      3. By Applications
      4. By End-users
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. AstraZeneca
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Amgen
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Bayer AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. F. Hoffman La-Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Bristol-Myers Squibb
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Merck
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Janssen Global Services, LLC
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Pfizer
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Novartis
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us